Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p3491 has 299 genes in the original annotation. Currently, there are 167 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
1390	CREM	CREM-2 \| ICER \| hCREM-2	cAMP responsive element modulator	10p11.21
10659	CELF2	BRUNOL3 \| CUGBP2 \| ETR-3 \| ETR3 \| NAPOR	CUGBP, Elav-like family member 2	10p13
10133	OPTN	ALS12 \| FIP2 \| GLC1E \| HIP7 \| HYPL \| NRP \| TFIIIA-INTP	optineurin	10p13
5551	PRF1	FLH2 \| HPLH2 \| P1 \| PFN1 \| PFP	perforin 1	10q22
729238	SFTPA2	COLEC5 \| PSAP \| PSP-A \| PSPA \| SFTP1 \| SFTPA2B \| SP-A \| SPA2 \| SPAII	surfactant protein A2	10q22.3
3434	IFIT1	C56 \| G10P1 \| IFI-56 \| IFI-56K \| IFI56 \| IFIT-1 \| IFNAI1 \| ISG56 \| P56 \| RNM561	interferon induced protein with tetratricopeptide repeats 1	10q23.31
10570	DPYSL4	CRMP3 \| DRP-4 \| ULIP4	dihydropyrimidinase like 4	10q26
8519	IFITM1	9-27 \| CD225 \| DSPA2a \| IFI17 \| LEU13	interferon induced transmembrane protein 1	11p15.5
10410	IFITM3	1-8U \| DSPA2b \| IP15	interferon induced transmembrane protein 3	11p15.5
4046	LSP1	WP34 \| pp52	lymphocyte-specific protein 1	11p15.5
10581	IFITM2	1-8D \| DSPA2c	interferon induced transmembrane protein 2	11p15.5
9246	UBE2L6	RIG-B \| UBCH8	ubiquitin conjugating enzyme E2 L6	11q12
7536	SF1	BBP \| D11S636 \| MBBP \| ZCCHC25 \| ZFM1 \| ZNF162	splicing factor 1	11q13
7351	UCP2	BMIQ4 \| SLC25A8 \| UCPH	uncoupling protein 2 (mitochondrial, proton carrier)	11q13
595	CCND1	BCL1 \| D11S287E \| PRAD1 \| U21B31	cyclin D1	11q13
3587	IL10RA	CD210 \| CD210a \| CDW210A \| HIL-10R \| IL-10R1 \| IL10R	interleukin 10 receptor subunit alpha	11q23
915	CD3D	CD3-DELTA \| IMD19 \| T3D	CD3d molecule	11q23
939	CD27	S152 \| S152. LPFS2 \| T14 \| TNFRSF7 \| Tp55	CD27 molecule	12p13
969	CD69	AIM \| BL-AC/P26 \| CLEC2C \| EA1 \| GP32/28 \| MLR-3	CD69 molecule	12p13
29951	PDZRN4	LNX4 \| SAMCAP3L	PDZ domain containing ring finger 4	12q12
3458	IFNG	IFG \| IFI	interferon, gamma	12q14
1368	CPM	-	carboxypeptidase M	12q14.3
4939	OAS2	-	2'-5'-oligoadenylate synthetase 2	12q24.2
26353	HSPB8	CMT2L \| DHMN2 \| E2IG1 \| H11 \| HMN2 \| HMN2A \| HSP22	heat shock protein family B (small) member 8	12q24.23
241	ALOX5AP	FLAP	arachidonate 5-lipoxygenase activating protein	13q12
26586	CKAP2	LB1 \| TMAP \| se20-10	cytoskeleton associated protein 2	13q14
8660	IRS2	IRS-2	insulin receptor substrate 2	13q34
64919	BCL11B	ATL1 \| ATL1-alpha \| ATL1-beta \| ATL1-delta \| ATL1-gamma \| CTIP-2 \| CTIP2 \| RIT1 \| ZNF856B \| hRIT1-alpha	B-cell CLL/lymphoma 11B	14q32.2
113146	AHNAK2	C14orf78	AHNAK nucleoprotein 2	14q32.33
10125	RASGRP1	CALDAG-GEFI \| CALDAG-GEFII \| RASGRP \| V \| hRasGRP1	RAS guanyl releasing protein 1	15q14
2200	FBN1	ACMICD \| ECTOL1 \| FBN \| GPHYSD2 \| MASS \| MFS1 \| OCTD \| SGS \| SSKS \| WMS \| WMS2	fibrillin 1	15q21.1
597	BCL2A1	ACC-1 \| ACC-2 \| ACC1 \| ACC2 \| BCL2L5 \| BFL1 \| GRS \| HBPA1	BCL2 related protein A1	15q24.3
11151	CORO1A	CLABP \| CLIPINA \| HCORO1 \| IMD8 \| TACO \| p57	coronin 1A	16p11.2
3683	ITGAL	CD11A \| LFA-1 \| LFA1A	integrin subunit alpha L	16p11.2
51704	GPRC5B	RAIG-2 \| RAIG2	G protein-coupled receptor class C group 5 member B	16p12
8651	SOCS1	CIS1 \| CISH1 \| JAB \| SOCS-1 \| SSI-1 \| SSI1 \| TIP3	suppressor of cytokine signaling 1	16p13.13
113	ADCY7	AC7	adenylate cyclase 7	16q12.1
267	AMFR	GP78 \| RNF45	autocrine motility factor receptor, E3 ubiquitin protein ligase	16q21
3394	IRF8	H-ICSBP \| ICSBP \| ICSBP1 \| IMD32A \| IMD32B \| IRF-8	interferon regulatory factor 8	16q24.1
8140	SLC7A5	4F2LC \| CD98 \| D16S469E \| E16 \| LAT1 \| MPE16 \| hLAT1	solute carrier family 7 member 5	16q24.3
9955	HS3ST3A1	3-OST-3A \| 3OST3A1	heparan sulfate-glucosamine 3-sulfotransferase 3A1	17p12
6355	CCL8	HC14 \| MCP-2 \| MCP2 \| SCYA10 \| SCYA8	C-C motif chemokine ligand 8	17q11.2
6351	CCL4	ACT2 \| AT744.1 \| G-26 \| HC21 \| LAG-1 \| LAG1 \| MIP-1-beta \| MIP1B \| MIP1B1 \| SCYA2 \| SCYA4	C-C motif chemokine ligand 4	17q12
6352	CCL5	D17S136E \| RANTES \| SCYA5 \| SIS-delta \| SISd \| TCP228 \| eoCP	C-C motif chemokine ligand 5	17q12
55106	SLFN12	SLFN3	schlafen family member 12	17q12
439921	MXRA7	PS1TP1 \| TMAP1	matrix-remodelling associated 7	17q25.1
1000	CDH2	CD325 \| CDHN \| CDw325 \| NCAD	cadherin 2	18q11.2
1264	CNN1	HEL-S-14 \| SMCC \| Sm-Calp	calponin 1	19p13.2
11184	MAP4K1	HPK1	mitogen-activated protein kinase kinase kinase kinase 1	19q13.1-q13.4
348	APOE	AD2 \| APO-E \| LDLCQ5 \| LPG	apolipoprotein E	19q13.2
4818	NKG7	GIG1 \| GMP-17 \| p15-TIA-1	natural killer cell granule protein 7	19q13.41
963	CD53	MOX44 \| TSPAN25	CD53 molecule	1p13
7482	WNT2B	WNT13	wingless-type MMTV integration site family member 2B	1p13
914	CD2	LFA-2 \| SRBC \| T11	CD2 molecule	1p13.1
2633	GBP1	-	guanylate binding protein 1	1p22.2
10964	IFI44L	C1orf29 \| GS3686	interferon induced protein 44 like	1p31.1
10561	IFI44	MTAP44 \| TLDC5 \| p44	interferon induced protein 44	1p31.1
7805	LAPTM5	CLAST6	lysosomal protein transmembrane 5	1p34
3932	LCK	IMD22 \| LSK \| YT16 \| p56lck \| pp58lck	LCK proto-oncogene, Src family tyrosine kinase	1p34.3
864	RUNX3	AML2 \| CBFA3 \| PEBP2aC	runt related transcription factor 3	1p36
712	C1QA	-	complement component 1, q subcomponent, A chain	1p36.12
713	C1QB	-	complement component 1, q subcomponent, B chain	1p36.12
79630	C1orf54	-	chromosome 1 open reading frame 54	1q21.2
23208	SYT11	SYT12 \| sytXI	synaptotagmin 11	1q21.2
962	CD48	BCM1 \| BLAST \| BLAST1 \| MEM-102 \| SLAMF2 \| hCD48 \| mCD48	CD48 molecule	1q21.3-q22
6504	SLAMF1	CD150 \| CDw150 \| SLAM	signaling lymphocytic activation molecule family member 1	1q23.3
6004	RGS16	A28-RGS14 \| A28-RGS14P \| RGS-R	regulator of G-protein signaling 16	1q25-q31
5996	RGS1	1R20 \| BL34 \| HEL-S-87 \| IER1 \| IR20	regulator of G-protein signaling 1	1q31
5778	PTPN7	BPTP-4 \| HEPTP \| LC-PTP \| LPTP \| PTPNI	protein tyrosine phosphatase, non-receptor type 7	1q32.1
23114	NFASC	NF \| NRCAML	neurofascin	1q32.1
4811	NID1	NID	nidogen 1	1q43
7056	THBD	AHUS6 \| BDCA3 \| CD141 \| THPH12 \| THRM \| TM	thrombomodulin	20p11.2
79953	SYNDIG1	C20orf39 \| DSPC2 \| IFITMD5 \| TMEM90B	synapse differentiation inducing 1	20p11.21
4318	MMP9	CLG4B \| GELB \| MANDP2 \| MMP-9	matrix metallopeptidase 9	20q13.12
64092	SAMSN1	HACS1 \| NASH1 \| SASH2 \| SH3D6B \| SLy2	SAM domain, SH3 domain and nuclear localization signals 1	21q11
9510	ADAMTS1	C3-C5 \| METH1	ADAM metallopeptidase with thrombospondin type 1 motif 1	21q21.2
2114	ETS2	ETS2IT1	ETS proto-oncogene 2, transcription factor	21q22.2
4599	MX1	IFI-78K \| IFI78 \| MX \| MxA	MX dynamin like GTPase 1	21q22.3
4600	MX2	MXB	MX dynamin like GTPase 2	21q22.3
3689	ITGB2	CD18 \| LAD \| LCAMB \| LFA-1 \| MAC-1 \| MF17 \| MFI7	integrin subunit beta 2	21q22.3
51816	CECR1	ADA2 \| ADGF \| IDGFL \| PAN \| SNEDS	cat eye syndrome chromosome region, candidate 1	22q11.2
7122	CLDN5	AWAL \| BEC1 \| CPETRL1 \| TMVCF	claudin 5	22q11.21
8542	APOL1	APO-L \| APOL \| APOL-I \| FSGS4	apolipoprotein L1	22q13.1
5880	RAC2	EN-7 \| Gx \| HSPC022 \| p21-Rac2	ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)	22q13.1
1439	CSF2RB	CD131 \| CDw131 \| IL3RB \| IL5RB \| SMDP5	colony stimulating factor 2 receptor beta common subunit	22q13.1
925	CD8A	CD8 \| Leu2 \| MAL \| p32	CD8a molecule	2p12
50489	CD207	CLEC4K	CD207 molecule	2p13
91543	RSAD2	2510004L01Rik \| cig33 \| cig5 \| vig1	radical S-adenosyl methionine domain containing 2	2p25.2
1844	DUSP2	PAC-1 \| PAC1	dual specificity phosphatase 2	2q11
7535	ZAP70	SRK \| STCD \| STD \| TZK \| ZAP-70	zeta chain of T cell receptor associated protein kinase 70kDa	2q12
7850	IL1R2	CD121b \| CDw121b \| IL-1R-2 \| IL-1RT-2 \| IL-1RT2 \| IL1R2c \| IL1RB	interleukin 1 receptor type 2	2q12
7852	CXCR4	CD184 \| D2S201E \| FB22 \| HM89 \| HSY3RR \| LAP-3 \| LAP3 \| LCR1 \| LESTR \| NPY3R \| NPYR \| NPYRL \| NPYY3R \| WHIM \| WHIMS	C-X-C motif chemokine receptor 4	2q21
4929	NR4A2	HZF-3 \| NOT \| NURR1 \| RNR1 \| TINUR	nuclear receptor subfamily 4 group A member 2	2q22-q23
55843	ARHGAP15	BM046	Rho GTPase activating protein 15	2q22.2-q22.3
6772	STAT1	CANDF7 \| IMD31A \| IMD31B \| IMD31C \| ISGF-3 \| STAT91	signal transducer and activator of transcription 1	2q32.2
9262	STK17B	DRAK2	serine/threonine kinase 17b	2q32.3
940	CD28	Tp44	CD28 molecule	2q33
5334	PLCL1	PLCE \| PLCL \| PLDL1 \| PPP1R127 \| PRIP	phospholipase C like 1	2q33
55619	DOCK10	DRIP2 \| Nbla10300 \| ZIZ3	dedicator of cytokinesis 10	2q36.2
1499	CTNNB1	CTNNB \| MRD19 \| armadillo	catenin beta 1	3p21
25907	TMEM158	BBP \| RIS1 \| p40BBP	transmembrane protein 158 (gene/pseudogene)	3p21.3
1234	CCR5	CC-CKR-5 \| CCCKR5 \| CCR-5 \| CD195 \| CKR-5 \| CKR5 \| CMKBR5 \| IDDM22	C-C motif chemokine receptor 5 (gene/pseudogene)	3p21.31
942	CD86	B7-2 \| B7.2 \| B70 \| CD28LG2 \| LAB72	CD86 molecule	3q21
27074	LAMP3	CD208 \| DC LAMP \| DC-LAMP \| DCLAMP \| LAMP \| LAMP-3 \| TSC403	lysosomal associated membrane protein 3	3q26.3-q27
10891	PPARGC1A	LEM6 \| PGC-1(alpha) \| PGC-1alpha \| PGC-1v \| PGC1 \| PGC1A \| PPARGC1	PPARG coactivator 1 alpha	4p15.1
152	ADRA2C	ADRA2L2 \| ADRA2RL2 \| ADRARL2 \| ALPHA2CAR	adrenoceptor alpha 2C	4p16
8532	CPZ	-	carboxypeptidase Z	4p16.1
26228	STAP1	BRDG1 \| STAP-1	signal transducing adaptor family member 1	4q13.2
4283	CXCL9	CMK \| Humig \| MIG \| SCYB9 \| crg-10	C-X-C motif chemokine ligand 9	4q21
55752	SEPT11	-	septin 11	4q21.1
51316	PLAC8	C15 \| DGIC \| PNAS-144 \| onzin	placenta specific 8	4q21.22
55008	HERC6	-	HECT and RLD domain containing E3 ubiquitin protein ligase family member 6	4q22.1
55601	DDX60	-	DEXD/H-box helicase 60	4q32.3
2823	GPM6A	GPM6 \| M6A	glycoprotein M6A	4q34
2533	FYB	ADAP \| PRO0823 \| SLAP-130 \| SLAP130	FYN binding protein	5p13.1
3003	GZMK	TRYP2	granzyme K	5q11.2
51752	ERAP1	A-LAP \| ALAP \| APPILS \| ARTS-1 \| ARTS1 \| ERAAP \| ERAAP1 \| PILS-AP \| PILSAP	endoplasmic reticulum aminopeptidase 1	5q15
3702	ITK	EMT \| LPFS1 \| LYK \| PSCTK2	IL2 inducible T-cell kinase	5q31-q32
3659	IRF1	IRF-1 \| MAR	interferon regulatory factor 1	5q31.1
5558	PRIM2	PRIM2A \| p58	primase (DNA) subunit 2	6p12-p11.1
730101	LOC730101	-	uncharacterized LOC730101	6p12.2
81578	COL21A1	COLA1L \| FP633	collagen type XXI alpha 1	6p12.3-p11.2\|6p12.3-p11.2
3106	HLA-B	AS \| Bw-47 \| Bw-50 \| HLAB \| SPDA1	major histocompatibility complex, class I, B	6p21.3
3107	HLA-C	D6S204 \| HLA-JY3 \| HLAC \| HLC-C \| PSORS1	major histocompatibility complex, class I, C	6p21.3
3115	HLA-DPB1	DPB1 \| HLA-DP \| HLA-DP1B \| HLA-DPB	major histocompatibility complex, class II, DP beta 1	6p21.3
3117	HLA-DQA1	CD \| CELIAC1 \| DQ-A1 \| GSE \| HLA-DQA	major histocompatibility complex, class II, DQ alpha 1	6p21.3
3119	HLA-DQB1	CELIAC1 \| HLA-DQB \| IDDM1	major histocompatibility complex, class II, DQ beta 1	6p21.3
3122	HLA-DRA	HLA-DRA1 \| MLRW	major histocompatibility complex, class II, DR alpha	6p21.3
3133	HLA-E	EA1.2 \| EA2.1 \| HLA-6.2 \| MHC \| QA1	major histocompatibility complex, class I, E	6p21.3
3134	HLA-F	CDA12 \| HLA-5.4 \| HLA-CDA12 \| HLAF	major histocompatibility complex, class I, F	6p21.3
3135	HLA-G	MHC-G	major histocompatibility complex, class I, G	6p21.3
352961	HCG26	3.8-1 \| NCRNA00191 \| bCX205D4.4 \| bPG181B23.4	HLA complex group 26 (non-protein coding)	6p21.3
6890	TAP1	ABC17 \| ABCB2 \| APT1 \| D6S114E \| PSF-1 \| PSF1 \| RING4 \| TAP1*0102N \| TAP1N	transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)	6p21.3
6891	TAP2	ABC18 \| ABCB3 \| APT2 \| D6S217E \| PSF-2 \| PSF2 \| RING11	transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)	6p21.3
5696	PSMB8	ALDD \| D6S216 \| D6S216E \| JMP \| LMP7 \| NKJO \| PSMB5i \| RING10	proteasome subunit beta 8	6p21.3
5698	PSMB9	LMP2 \| PSMB6i \| RING12 \| beta1i	proteasome subunit beta 9	6p21.3
3137	HLA-J	CDA12 \| D6S203 \| HLA-59 \| HLA-CDA12	major histocompatibility complex, class I, J (pseudogene)	6p21.31
8418	CMAHP	CMAH \| CSAH	cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene	6p21.32
11118	BTN3A2	BT3.2 \| BTF4 \| BTN3.2 \| CD277	butyrophilin subfamily 3 member A2	6p22.1
11119	BTN3A1	BT3.1 \| BTF5 \| BTN3.1 \| CD277	butyrophilin subfamily 3 member A1	6p22.1
9308	CD83	BL11 \| HB15	CD83 molecule	6p23
54898	ELOVL2	SSC2	ELOVL fatty acid elongase 2	6p24.2
2534	FYN	SLK \| SYN \| p59-FYN	FYN proto-oncogene, Src family tyrosine kinase	6q21
4602	MYB	Cmyb \| c-myb \| c-myb_CDS \| efg	MYB proto-oncogene, transcription factor	6q22-q23
5723	PSPH	PSP \| PSPHD	phosphoserine phosphatase	7p11.2
10875	FGL2	T49 \| pT49	fibrinogen like 2	7q11.23
5166	PDK4	-	pyruvate dehydrogenase kinase 4	7q21.3
10156	RASA4	CAPRI \| GAPL	RAS p21 protein activator 4	7q22
79037	PVRIG	C7orf15	poliovirus receptor related immunoglobulin domain containing	7q22.1
22797	TFEC	TCFEC \| TFE-C \| TFEC-L \| TFECL \| bHLHe34 \| hTFEC-L	transcription factor EC	7q31.2
1052	CEBPD	C/EBP-delta \| CELF \| CRP3 \| NF-IL6-beta	CCAAT/enhancer binding protein delta	8p11.2-p11.1
3620	IDO1	IDO \| IDO-1 \| INDO	indoleamine 2,3-dioxygenase 1	8p11.21
1191	CLU	AAG4 \| APO-J \| APOJ \| CLI \| CLU1 \| CLU2 \| KUB1 \| NA1/NA2 \| SGP-2 \| SGP2 \| SP-40 \| TRPM-2 \| TRPM2	clusterin	8p21-p12
27299	ADAMDEC1	M12.219	ADAM-like, decysin 1	8p21.2
9	NAT1	AAC1 \| MNAT \| NAT-1 \| NATI	N-acetyltransferase 1 (arylamine N-acetyltransferase)	8p22
10395	DLC1	ARHGAP7 \| HP \| STARD12 \| p122-RhoGAP	DLC1 Rho GTPase activating protein	8p22
51050	PI15	CRISP8 \| P24TI \| P25TI	peptidase inhibitor 15	8q21.11
23643	LY96	ESOP-1 \| MD-2 \| MD2 \| ly-96	lymphocyte antigen 96	8q21.11
6503	SLA	SLA1 \| SLAP	Src-like-adaptor	8q24
6363	CCL19	CKb11 \| ELC \| MIP-3b \| MIP3B \| SCYA19	C-C motif chemokine ligand 19	9p13
7091	TLE4	BCE-1 \| BCE1 \| E(spI) \| ESG \| ESG4 \| GRG4 \| Grg-4	transducin like enhancer of split 4	9q21.31
8013	NR4A3	CHN \| CSMF \| MINOR \| NOR1 \| TEC	nuclear receptor subfamily 4 group A member 3	9q22
2040	STOM	BND7 \| EPB7 \| EPB72	stomatin	9q34.1
5730	PTGDS	L-PGDS \| LPGDS \| PDS \| PGD2 \| PGDS \| PGDS2	prostaglandin D2 synthase	9q34.2-q34.3
11326	VSIG4	CRIg \| Z39IG	V-set and immunoglobulin domain containing 4	Xq12-q13.3
3561	IL2RG	CD132 \| CIDX \| IL-2RG \| IMD4 \| P64 \| SCIDX \| SCIDX1	interleukin 2 receptor subunit gamma	Xq13.1
1193	CLIC2	CLIC2b \| MRXS32 \| XAP121	chloride intracellular channel 2	Xq28